Company profile: Pharm-Olam
1.1 - Company Overview
Company description
- Provider of comprehensive clinical research services as a multi-national contract research organization serving pharmaceutical, biotechnology, and medical device industries, with a global network including Central Eastern Europe, Latin America, and India to enable patient recruitment.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Pharm-Olam
Minerva Imaging
HQ: Denmark
Website
- Description: Provider of contract research services for translational cancer research and drug development, offering molecular imaging, oncology, radionuclide therapy, and cardiovascular disease services. Responds to customer inquiries via phone, contact form, and email.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Minerva Imaging company profile →
Parexel
HQ: United States
Website
- Description: Provider of biopharmaceutical services, including clinical research, medical communications, consulting, commercialization, and advanced technology for pharmaceutical, biotechnology, and medical device industries. Offerings include clinical trial management, RWE and late phase research, market access strategy, regulatory compliance and pharmacovigilance, and advanced analytics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Parexel company profile →
Clintrak
HQ: United States
Website
- Description: Provider of clinical-trial printing and labeling solutions, including design and production of single panel and booklet labels for use in clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clintrak company profile →
Florida Pharma Products
HQ: United States
Website
- Description: Provider of generic prescription pharmaceuticals, covering development, sales, marketing, and distribution across therapeutic areas. Also provides R&D to identify new treatments, project management from R&D to commercialization, business development via licensing, acquisition, profit-sharing and development partnerships, plus operations to reduce costs and increase productivity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Florida Pharma Products company profile →
Biorasi
HQ: United States
Website
- Description: Provider of contract research services for complex clinical trials, offering safety and pharmacovigilance (medical coding, case processing, data monitoring, safety management, annual reporting), clinical trial rescue (patient recruitment, site activation, logistical coordination), CAR T-cell therapy trial management (cell collection, modification, reinfusion), and precision medicine through pharmacogenomics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biorasi company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Pharm-Olam
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Pharm-Olam
2.2 - Growth funds investing in similar companies to Pharm-Olam
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Pharm-Olam
4.2 - Public trading comparable groups for Pharm-Olam
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →